News from the BioCity Campus

Saxony lifts application freeze for research and development projects

The Saxon Ministry of Economic Affairs has lifted the application freeze for research and development projects (R&D) within the Saxon ERDF technology funding 2014 to 2020 for a limited period of time. Due to high demand, the application freeze for new R&D projects had existed since December 2019. From now until the end of January 2021, Saxon companies can again submit R&D project applications with a maximum term of 18 months to the Saxon development bank – development bank – (SAB) Submit. The substantive selection criteria such as degree of innovation, marketability and exploitation perspective remain valid. Around eight million euros are available for this funding tranche.

Saxony's Economics Minister Martin Dulig: »Saxon companies are innovative and have excellent ideas for new products and processes. Especially in the time of the corona pandemic, companies want to do more research themselves and develop their own marketable products from their ideas. I am pleased that we can support the companies with the funds that are still available from the current funding period of the European Regional Development Fund.«

The SAB is now accepting applications. Information on how to apply can be found at SAB website.

Since the start of the funding period from 2014 to 2020, Saxony has approved grants of around 1.100 million euros for over 486 research and development projects by Saxon companies and their partners within the framework of the Saxon ERDF technology funding. Many of these projects will run into 2022.

Source: SMWA press release from October 1.12.2020th, XNUMX

previous news

Quo vadis, MDR and DVG?

How can medium-sized companies and start-ups adapt to the new requirements of the MDR and DVG? A free event by biosaxony and WIG2 on December 16th and 17th, 2020 will present best practices.


Action paper NanoBioMedizin 2020 published

In order to ensure competitive research, development and market launch of advanced materials and especially nanomaterials in Germany, the action paper NanoBioMedizin 2020 names and defines the main challenges, topics with a high need for research and development as well as important areas of action to improve patient care.